There are 2789 resources available
336TiP - Ipatasertib plus non-taxane chemotherapy for metastatic triple-negative breast cancer (TNBC): Pathfinder trial
Presenter: Antonio Llombart Cussac
Session: ePoster Display
337TiP - An open-label, phase Ib/II study to evaluate the safety and efficacy of fruquintinib in combination with tislelizumab in patients with advanced triple-negative breast cancer
Presenter: Debu Tripathy
Session: ePoster Display
338TiP - CAPItello-292: A phase 1b/3 study of capivasertib, palbociclib and fulvestrant versus placebo, palbociclib and fulvestrant in HR+/HER2− advanced breast cancer
Presenter: Erika Hamilton
Session: ePoster Display
339TiP - SOLTI-1502 ARIANNA: Targeting PAM50 HER2-enriched intrinsic subtype with enzalutamide in hormone receptor-positive/HER2-negative metastatic breast cancer
Presenter: Luis Manso
Session: ePoster Display
348P - Up-regulation of sorcin promotes glioblastoma progression via activating the PI3K/AKT/mTOR pathway
Presenter: Zhangya Pu
Session: ePoster Display
349P - The amount of cancer stem cells and the sensitivity to anticancer drugs in glioblastoma primary cell culture
Presenter: Olga Susova
Session: ePoster Display
350P - Molecular profiling of tumor tissue and tumor-derived cell lines in patients with glioblastoma
Presenter: Tatiana Nasedkina
Session: ePoster Display
351P - Impact of time to initiation post-operative adjuvant chemo-radiation in glioblastoma multiform: A systematic review
Presenter: Sudibio Sudibio
Session: ePoster Display
372P - The prognostic value of liver metastases and how affects the applicability of the lung-molGPA in non-small cell lung cancer patients with brain metastases
Presenter: Joel Rafael Veas Rodriguez
Session: ePoster Display
373P - Brain metastases: Extracranial disease status as a prognostic factor after whole brain radiotherapy. Results from a prospective, population-based study
Presenter: Olav Yri
Session: ePoster Display